Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of long-term biochemical control and the kinetics of recurrence in patients treated at Stanford University

The Journal of Urology
S L HancockM A Bagshaw

Abstract

We evaluated prostate specific antigen (PSA) evidence for control of prostatic cancer after irradiation. We studied 110 patients for whom more than 2 PSA measurements were obtained to establish trends and the initial measurement was done between April 1985 and January 1988. A total of 42 patients (38%) had stable, normal PSA levels with followup averaging 12.4 years (range 4.4 to 24.8). Increasing clinical stage or Gleason score correlated significantly with risk for PSA relapse, as did pretreatment PSA level. Short PSA doubling times were associated with distant metastasis rather than with local recurrence. We found that irradiation durably controlled 38% of prostatic cancers of various stages and grades and is unlikely to accelerate tumor growth.

References

Aug 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RitterT J Kinsella
Nov 1, 1990·The Journal of Urology·I KaplanM A Bagshaw
Sep 1, 1990·International Journal of Radiation Oncology, Biology, Physics·P P LaiM A Lockett
Feb 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M TaylorW M Mendenhall
Jan 1, 1994·International Journal of Radiation Oncology, Biology, Physics·R S CoxM A Bagshaw
Aug 25, 1993·JAMA : the Journal of the American Medical Association·W J CatalonaJ W Basler
Nov 1, 1994·The Journal of Urology·M A BagshawS L Hancock

❮ Previous
Next ❯

Citations

Jul 1, 1985·International Journal of Radiation Oncology, Biology, Physics·G E Hanks
May 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A Pollack, G K Zagars
Apr 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stephen A MangarAlan Horwich
Aug 1, 1996·Urology·J K Cohen
Jun 7, 1997·Lancet·M FrydenbergK W Kaye
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Alan PollackEric M Horwitz
Mar 15, 1997·International Journal of Radiation Oncology, Biology, Physics·M S AnscherM W Dewhirst
Oct 19, 1999·International Journal of Radiation Oncology, Biology, Physics·F A ViciniA A Martinez
Mar 1, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yasutomo NasuHiromi Kumon
Jun 27, 2014·BioMed Research International·Flavio Barchetti, Valeria Panebianco
Jul 29, 2011·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·S SupiotJ Rigaud
Apr 24, 2013·Actas urologicas españolas·C HernándezJ M Cózar
Nov 1, 1996·The Urologic Clinics of North America·G E Hanks
Nov 1, 1996·The Urologic Clinics of North America·E T Goluboff, M C Benson
Mar 31, 2010·Scandinavian Journal of Urology and Nephrology·Viktor BergeSteinar Johan Karlsen
Mar 16, 2001·Expert Opinion on Pharmacotherapy·D K Ornstein, R S Pruthi
Jun 1, 1996·Hematology/oncology Clinics of North America·A C Hartford, A L Zietman
Dec 25, 2007·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Michel SouliéArnauld Villers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.